School-Age Follow Up of the Transfusion of Prematures (TOP) Trial: Neurodevelopmental Outcomes by Hemoglobin Transfusion Thresholds

Amy L. Conrad, The University of Iowa, Iowa City, IA, United States; Sara DeMauro, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Sylvia M. Tan, 001924420833, Washington, DC, United States; Haresh Kirpalani, McMaster University Michael G. DeGroote School of Medicine, Burlington, ON, Canada; Kristina Ziolkowski, Childrens Hospital of Philadelphia, Phiadelphia, PA, United States; Susan R.. Hintz, Stanford University School of Medicine, Palo Alto, CA, United States; Betty R. Vohr, Women & Infants Hospital, Alpert Medical School of Brown University, Bristol, RI, United States; Victoria E. Watson, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Tarah Colaizy, University of Iowa Stead Family Children's Hospital, Iowa City, IA, United States; Edward F. Bell, University of Iowa, Iowa City, IA, United States; Jane E. Brumbaugh, Mayo Clinic, Rochester, MN, United States; Carla M. Bann, RTI International, Apex, NC, United States; Jamie E. Newman, RTI International, Research Triangle Park, NC, United States; Abhik Das, RTI, Gaithersburg, MD, United States; on behalf of NICHD Neonatal Research Network, NICHD Neonatal Research Network, Bethesda, MD, United States